The IAI-OCTA Study or; Microvascular Structure and Morphology of Neovascular Membranes in Age Related Macular Degeneration (AMD) After Intravitreal Aflibercept Injection (IAI) Therapy Using OCT-Angiography Analysis
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2019
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms IAI-OCTA
- 21 Dec 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2021.
- 21 Dec 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2020.
- 26 Apr 2017 Status changed from not yet recruiting to recruiting.